Gene: LURAP1L
Official Full Name: leucine rich adaptor protein 1 likeprovided by HGNC
Gene Summary: Predicted to be involved in regulation of signal transduction. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16420 | LURAP1L Knockout cell line (HeLa) | Human | LURAP1L | 1:3~1:6 | Negative | Online Inquiry |
KO16421 | LURAP1L Knockout cell line (HCT 116) | Human | LURAP1L | 1:2~1:4 | Negative | Online Inquiry |
KO16422 | LURAP1L Knockout cell line (HEK293) | Human | LURAP1L | 1:3~1:6 | Negative | Online Inquiry |
KO16423 | LURAP1L Knockout cell line (A549) | Human | LURAP1L | 1:3~1:4 | Negative | Online Inquiry |
LURAP1L Gene Knockout Cell Lines are specialized cellular models engineered to lack the LURAP1L gene, which plays a crucial role in various biological processes, including immune response regulation and cellular signaling pathways. These cell lines are created using advanced CRISPR-Cas9 gene-editing technology, allowing for precise and efficient deletion of the LURAP1L gene. By studying these models, researchers can uncover the gene's functions and its impact on cellular behaviors, particularly in the context of cancer biology, inflammation, and immune system disorders.
The primary mechanism of action lies in the precise editing of genomic sequences, which results in the absence of LURAP1L expression. This knockout approach enables scientists to delve into the gene's role by comparing the knockout lines with wild-type counterparts. Researchers can observe phenotypic changes, alterations in signaling pathways, and various cellular responses, enhancing our understanding of the gene's contribution to disease mechanisms and physiological processes.
The scientific importance of LURAP1L Gene Knockout Cell Lines extends to both basic research and clinical applications. In a research setting, these cell lines serve as invaluable tools for elucidating pathways that may be targetable for therapeutic intervention. In clinical contexts, understanding the role of LURAP1L may lead to novel biomarker identification or the development of innovative treatments aimed at diseases involving the immune system and cancer.
Unique selling points of our knockout cell lines include their robust quality through stringent validation processes, ease of use in various experimental setups, and compatibility with high-throughput screening applications. Compared to other gene-editing products, our lines offer superior background consistency and reproducibility of results, critical for obtaining reliable data in research initiatives.
Researchers and clinicians will find LURAP1L Gene Knockout Cell Lines indispensable for advancing their investigations into novel therapeutic avenues. By utilizing these cell lines, they can accelerate the pace of discovery in understanding complex disease networks.
Our company specializes in providing high-quality biological products tailored to support cutting-edge research. With our commitment to scientific excellence and customer satisfaction, researchers can trust our offerings to drive innovation and discovery in their work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.